Unum Therapeutics Announces Transition of Chief Financial Officer
CAMBRIDGE, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) — Unum Therapeutics Inc. (NASDAQ: UMRX), a clinical-stage biopharmaceutical company focused on the […]
Constellation Pharmaceuticals Provides Update on MANIFEST Clinical Trial of CPI-0610 in Myelofibrosis, Reviews 2018 Accomplishments, and Announces 2019 Data Disclosure Plans for Lead Programs
Constellation CEO Jigar Raythatha will present at the J.P. Morgan Healthcare Conference on Wednesday, January 9, 2019, at 4PM PST/7PM […]
Eve & Co Announces Board Appointment of Ms. Shari Mogk-Edwards
TORONTO, Jan. 03, 2019 (GLOBE NEWSWIRE) — Eve & Co Incorporated (the “Company” or “Eve & Co”) (TSXV: EVE; OTCQB: […]
Sintana Energy Inc. Announces Election of Additional Independent Director
TORONTO, Jan. 03, 2019 (GLOBE NEWSWIRE) — Sintana Energy Inc. (“Sintana” or the “Company”) (TSXV: SEI) is pleased to announce […]
CTG Announces Agreement to Acquire Luxembourg-based Tech-IT
Transaction Further Extends European Market Leadership with Addition of Complementary Offerings That Enable End-to-End IT Solutions BUFFALO, N.Y., Jan. 03, […]
RPT Realty Completes $123.0 Million of Dispositions in 2018
NEW YORK, Jan. 03, 2019 (GLOBE NEWSWIRE) — RPT Realty (“RPT” or the “Company”) (NYSE: RPT) today announced that it […]
Park Electrochemical Corp. Reports Third Quarter Results and Declares Special Cash Dividend
THIRD QUARTER RESULTS MELVILLE, N.Y., Jan. 03, 2019 (GLOBE NEWSWIRE) — Park Electrochemical Corp. (NYSE-PKE) reported results for the 2019 […]
Ohr Pharmaceutical, Inc. Announces Merger Agreement with NeuBase Therapeutics, Inc.
Proposed combined company’s peptide-nucleic acid antisense oligonucleotide (PATrOL™) technology platform enables rapid development of therapies delivered systemically for genetic [...]
LHC Group to Present at 37th Annual J.P. Morgan Healthcare Conference
LAFAYETTE, La., Jan. 03, 2019 (GLOBE NEWSWIRE) — LHC Group, Inc. (NASDAQ: LHCG) announced today that the Company is presenting […]
Verrica Achieves Positive Topline Results from Two Pivotal Phase 3 Clinical Trials of VP-102 in Patients with Molluscum Contagiosum
CAMP-1 and CAMP-2 Phase 3 pivotal trials for molluscum contagiosum both achieve statistical significance for the primary endpoint with p-values […]
